Literature DB >> 16023094

Host-derived circulating cells do not significantly contribute to cardiac regeneration in heterotopic rat heart transplants.

Simonetta Ausoni1, Tania Zaglia, Arben Dedja, Raffaella Di Lisi, Michela Seveso, Ermanno Ancona, Gaetano Thiene, Emanuele Cozzi, Stefano Schiaffino.   

Abstract

OBJECTIVES: The aim of this study was to investigate the contribution of host-derived circulating cells to cardiac repair after tissue damage using the model of heterotopic heart transplantation between transgenic recipient rats expressing green fluorescent protein (GFP) and wild-type donors.
METHODS: Unlabeled donor rat hearts, some of which underwent prolonged cold ischemia pretreatment, were transplanted into the abdominal cavity of GFP+ transgenic recipient rats and were analyzed 15 and 90 days after surgery. An additional experimental group underwent heart transplantation following administration of granulocyte-colony stimulatory factor (G-CSF) to mobilize bone marrow cells.
RESULTS: Most transplants contained GFP+ mature cardiomyocytes. However, systematic counting in the transplants showed that the proportion of GFP+ cardiomyocytes was only 0.0005% to 0.008% of all cardiomyocytes. These relative proportions did not change after G-CSF treatment, despite evidence for sustained marrow cell mobilization. Confocal image analysis showed that the majority of GFP+ cardiomyocytes contained a high number of nuclei, suggesting that these cells may derive from fusion events. Very rarely, small GFP+ undifferentiated cells, expressing GATA-4, were also identified. Occasionally, GFP+ endothelial cells, but not smooth muscle cells, were detected in blood vessels of some transplants.
CONCLUSIONS: Our results demonstrate that cardiomyocytes expressing a host transgenic marker are detectable in heterotopic heart transplants; however, they do not significantly contribute to repopulation of the damaged myocardium.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16023094     DOI: 10.1016/j.cardiores.2005.06.014

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  7 in total

Review 1.  Stem cells and cardiac repair: a critical analysis.

Authors:  Jonathan H Dinsmore; Nabil Dib
Journal:  J Cardiovasc Transl Res       Date:  2008-01-31       Impact factor: 4.132

2.  Postinfarction healing dynamics in the mechanically unloaded rat left ventricle.

Authors:  Xin Zhou; Ji-Li Yun; Zhi-Qi Han; Fei Gao; He Li; Tie-Min Jiang; Yu-Ming Li
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-03-11       Impact factor: 4.733

3.  Spontaneous Formation of Extensive Vessel-Like Structures in Murine Engineered Heart Tissue.

Authors:  Andrea Stoehr; Marc N Hirt; Arne Hansen; Moritz Seiffert; Lenard Conradi; June Uebeler; Florian P Limbourg; Thomas Eschenhagen
Journal:  Tissue Eng Part A       Date:  2016-02       Impact factor: 3.845

4.  Optimized protocol for immunostaining of experimental GFP-expressing and human hearts.

Authors:  Tania Zaglia; Anna Di Bona; Tatiana Chioato; Cristina Basso; Simonetta Ausoni; Marco Mongillo
Journal:  Histochem Cell Biol       Date:  2016-06-17       Impact factor: 4.304

5.  Hematopoietic bone marrow cells participate in endothelial, but not epithelial or mesenchymal cell renewal in adult rats.

Authors:  Kathrin I Odörfer; Monika Egerbacher; Nina J Unger; Karin Weber; Angelika Jamnig; Günter Lepperdinger; Miriam Kleiter; Eric P Sandgren; Reinhold G Erben
Journal:  J Cell Mol Med       Date:  2011-08-04       Impact factor: 5.310

Review 6.  It is all in the blood: the multifaceted contribution of circulating progenitor cells in diabetic complications.

Authors:  Gian Paolo Fadini; Angelo Avogaro
Journal:  Exp Diabetes Res       Date:  2012-04-03

7.  Role of endogenous bone marrow cells in long-term repair mechanisms after myocardial infarction.

Authors:  Kathrin I Odörfer; Ingrid Walter; Miriam Kleiter; Eric P Sandgren; Reinhold G Erben
Journal:  J Cell Mol Med       Date:  2008-12       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.